Screener
Design Therapeutics, Inc. DSGN Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Design Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026.
- Filed
- Apr 28, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-187063
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Purchases of investment securities | (52,589) | (86,548) |
| Proceeds from maturities of investment securities | 45,000 | 94,490 |
| Purchases of property and equipment | — | (72) |
| Net cash (used in) provided by investing activities | (7,589) | 7,870 |
| Cash flows from financing activities | ||
| Proceeds from the issuance of common stock in at-the-market offering, net of issuance costs | 19,907 | — |
| Proceeds from the exercise of stock options | 27 | 23 |
| Net cash provided by financing activities | 19,934 | 23 |
Item 1. Financial Statements.
FAQ
- What is Design Therapeutics, Inc.'s investing cash flow?
- Design Therapeutics, Inc. (DSGN) reported investing cash flow of -$7.59M in Q1 2026.
- How has Design Therapeutics, Inc.'s investing cash flow changed year-over-year?
- Design Therapeutics, Inc.'s investing cash flow decreased by 196.4% year-over-year, from $7.87M to -$7.59M.
- What is the long-term trend for Design Therapeutics, Inc.'s investing cash flow?
- Over 2 years (2021 to 2023), Design Therapeutics, Inc.'s investing cash flow has grown at a -1.0% compound annual growth rate (CAGR), from -$53.64M to $52.54M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Design Therapeutics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude